SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-054746
Filing Date
2018-10-22
Accepted
2018-10-22 16:31:13
Documents
1
Period of Report
2018-10-18
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv505169_8k.htm 8-K 16589
  Complete submission text file 0001144204-18-054746.txt   17787
Mailing Address 1 BRIDGE PLAZA N, SUITE 270 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA N, SUITE 270 FORT LEE NJ 07024 201-464-2677
IMMUNE PHARMACEUTICALS INC (Filer) CIK: 0001208261 (see all company filings)

IRS No.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36602 | Film No.: 181132559
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences